Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GSK · against 454 other Healthcare companies listed in US-listed
Ranked #192 of 455 · scores higher than 57% of peers
Bars: peers in each 10-point band of the growth score52 peers with a growth score of 70–79, including GSK · Click a bar to see the companies
Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
| Metric | GSK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 4.1% | 11.0% | 31% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 121.9% | 21.2% | 83% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 3.7% | 11.0% | 30% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 188 | 63.0B USD | 73 | 65 | |
| 188 | 243M USD | 73 | 56 | |
| 188 | 155.7B USD | 73 | 64 | |
| 188 | 787M USD | 73 | 57 | |
| 192 | 97.5B USD | 72 | 67 | |
| 192 | 561M USD | 72 | 74 | |
| 192 | 1.3B USD | 72 | 44 | |
| 195 | 296M USD | 71 | 26 | |
| 195 | 8.4B USD | 71 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score